934-60-1

Basic information

• Product Name: 6-Methyl-2-pyridinecarboxylic acid
• Synonyms: 2-Pyridinecarboxylic acid, 6-methyl-;Picolinic acid, 6-methyl-;2-Carboxylic Acid-6-Methyl Pyridine;6-METHYLPICOLINIC ACID 98+%;6-METHYL PYRIDINE-2-CARBOXYLIC ACID HCL;6-Methylpicolinic acid,97%;6-Methylpyridine-2-carboxylic acid,6-Methylpicolinic acid;6-Methyl-2-pyridinecarboxylic Acid, 95+%
• CAS NO: 934-60-1
• Molecular Formula: C₇H₇NO₂
• Molecular Weight: 137.14
• EINECS: 213-287-4
• Product Categories: pharmacetical;NULL
• Mol File: 934-60-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 130 °C
• Boiling Point: 100°C/4.5mm
• Flash Point: 100°C/4.5mm
• Appearance: /
• Density: 1.23 g/cm³
• Vapor Pressure: 0.00148mmHg at 25°C
• Refractive Index: 1.561
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: pK1:5.83 (25°C)
• Water Solubility: Soluble in water
• CAS DataBase Reference: 6-Methyl-2-pyridinecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Methyl-2-pyridinecarboxylic acid(934-60-1)
• EPA Substance Registry System: 6-Methyl-2-pyridinecarboxylic acid(934-60-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39-36
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 934-60-1(Hazardous Substances Data)

Usage

Chemical Properties

White to beige powder

Uses

Pharmacological activity studied in regard to: Interactions of carrier ligands of antidiabetic metal complexes with human serum albuminAbility to chelate metalloenzyme inhibitorsInteractions of insulin-mimetic zinc(II) complexes with cell constituentsReactant for: Synthesis of inhibitors of human 11β -hydroxysteroid dehydrogenase type 1Lewis base organocatalysts for stereoselective hydrosilylation reactionsBiological studies of insulin-enhancing complexes

General Description

6-Methylpyridine-2-carboxylic acid (2-carboxy-6-methylpyridine, 6-methylpicolinic acid) is a heterocyclic building block.

InChI:InChI=1/C7H7NO2/c1-5-3-2-4-6(8-5)7(9)10/h2-4H,1H3,(H,9,10)

Upstream product

• 108-48-5 2,6-dimethylpyridine 
• 1122-72-1 6-methyl-2-pyridinecarboxaldehyde 
• 934-78-1 2-(6-methylpyridin-2-yl)-ethanol 
• 488-17-5 3-methylbenzene-1,2-diol 
• 7732-18-5 water 
• 13602-11-4 6-methylpicolinic acid methyl ester 
• 5315-25-3 2-bromo-6-methylpyridine 
• 1073-23-0 2,6-lutidine N-oxide 
• 1122-71-0 2-(Hydroxymethyl)-6-methylpyridine 
• 13287-64-4 acetic acid 6-methyl-pyridin-2-ylmethyl ester 
• 68470-59-7 2-(bromomethyl)-6-methylpyridine 
• 3279-76-3 6-hydroxy-2-methylpyridine 
• 124-38-9 carbon dioxide 

Downstream Products

• 39640-51-2 ethyl 6-methylpyridine-2-carboxylate 
• 58283-31-1 (4-Methoxy-phenyl)-(6-methyl-[2]pyridyl)-methanol 
• 1125-34-4 6-methyl-1-oxy-pyridine-2-carboxylic acid 
• 64819-72-3 2-(6-methylpyridin-2-yl)-benzooxazole 
• 99571-58-1 6-methylpiperidine-2-carboxylic acid 
• 13602-11-4 6-methylpicolinic acid methyl ester 
• 733806-23-0 6-methylpyridine-2-carboxylic acid (2-carbamoylphenyl)amide 
• 31749-13-0 α-(3,4-dimethoxyphenyl)-α-(6-methyl-2-pyridinyl)methanol 
• 59880-60-3 α-(3,5-dimethoxyphenyl)-α-(6-methyl-2-pyridinyl)methanol 
• 18103-78-1 (6-methylpyridin-2-yl)(phenyl)methanone 
• 1239316-22-3 C₁₇H₁₈N₂O₄ 
• 476471-33-7 N-methoxy-N,6-dimethylpyridine-2-carboxamide 
• 575433-87-3 tert-butyl 6-(methyl)picolinate 
• 1581755-59-0 (S)-(6-((1-phenylethyl)carbamoyl)pyridin-2-yl)methyl acetate 

Relevant articles and documents

Growth Factor Receptor antagonists. Preparation method and application thereof

The invention relates to a small molecule antagonist for transforming growth factor β receptors, a method for preparing the small molecule antagonist, and application of the small molecule antagonist in preparation of drugs. The small molecule antagonist for transforming the growth factor β receptor has the application of treating and/or preventing various diseases mediated by ALK5, and has great clinical application potential.

Polysubstituted pyridine medical intermediate and synthetic method thereof

The invention belongs to the field of medicine intermediate technology, and specifically relates to a polysubstituted pyridine medical intermediate and a synthetic method thereof. The polysubstituted pyridine medical intermediate is a key intermediate in pharmaceutical synthesis, and has a huge market potential. The synthetic method has simple synthetic route, simple and easily available staring material, and has great meaning in synthesis of pyridine intermediate, development of pyridine medicament and research and development of novel medicament, and the product is cheap.

ARYL SULFONAMIDES

The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.